Amgen Czech Republic is a Czech Republic-based subsidiary of the global pharmaceutical company Amgen. Amgen entered the Czech market in May 2004 folowing the entrance of the country into the EU. Now, the Czech subsidiary employes around 60 people with sales accounting for over USD 20 mil. Amgen (Applied Molecular Genetics) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. Located in the Conejo Valley, Amgen is the world's largest independent biotechnology firm. In 2013, the company's largest selling product lines were Neulasta/Neupogen, two closely related drugs used to prevent infections in patients undergoing cancer chemotherapy; and Enbrel, a tumor necrosis factor blocker used in the treatment of rheumatoid arthritis and other autoimmune diseases. Other products include Epogen, Aranesp, Sensipar/Mimpara, Nplate, Vectibix, Prolia and XGEVA.
This report offers a summary of the company's performance in 2005-2012. You will find here all the key numbers from the company's balance sheet, income statement and cash flow on the annual, in the local currency as well as in USD
Helgi Library 
